Viking Therapeutics VKTX
NASDAQ VKTX
$24.49 -1.34 (-5.19%)
As of: Oct 23, 2026 · 2:15 PM EDT

Viking Therapeutics (VKTX) Return on Capital Employed [ROCE] (2015 - 2026)

Updated

Viking Therapeutics (VKTX) recorded Return on Capital Employed [ROCE] of -122.97% in Q2 2026, down 96.87 percentage points from -26.10% a year earlier and down 32.63 percentage points from the prior quarter.

Analysis

Viking Therapeutics (VKTX) Return on Capital Employed [ROCE] (2015 - 2026) Analysis & Trends

For FY2025, Viking Therapeutics reported Return on Capital Employed [ROCE] of -53.49%, down 28.79 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has a five-year change of -36.97 percentage points (FY2020 to FY2025).
  • Across earlier years, Return on Capital Employed [ROCE] came in at -24.70% in FY2024 (+15.73 pp), -40.43% in FY2023 (+1.53 pp), -41.97% in FY2022 (-17.20 pp) and -24.77% in FY2021 (-8.25 pp).
  • The Q2 2026 figure is the lowest quarterly Return on Capital Employed [ROCE] since Q4 2017.
  • On a year-over-year basis, Return on Capital Employed [ROCE] has declined for six consecutive quarters, with an average year-over-year change of -28.26 percentage points over the last eight quarters.
  • Peak year-over-year performance for Return on Capital Employed [ROCE] in the last five years was a gain of 33.81 percentage points in Q1 2024, against a drop of 96.87 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -90.34% (Q1 2026), -60.43% (Q4 2025) and -36.28% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,127.42 Bn 1,096.00 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 633.77 Bn 553.63 Bn 17.30 Bn 17.52%
3 AbbVie 505.19 Bn 478.30 Bn 12.70 Bn 17.92%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 6.28%
5 Novartis Ag 290.00 Bn 253.99 Bn 11.24 Bn 19.32%
6 Astrazeneca 265.19 Bn 238.88 Bn 12.86 Bn 16.76%
7 Amgen 238.02 Bn 193.42 Bn 7.24 Bn 16.66%
8 Gilead Sciences 194.79 Bn 168.99 Bn 6.22 Bn -5.97%
9 Pfizer 171.11 Bn 117.76 Bn 10.94 Bn 11.86%
10 Viking Therapeutics 2.85 Bn 323.08 Mn - -122.97%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -122.97%
Mar 31, 2026 -90.34%
Dec 31, 2025 -60.43%
Sep 30, 2025 -36.28%
Jun 30, 2025 -26.10%
Mar 31, 2025 -19.85%
Dec 31, 2024 -16.85%
Sep 30, 2024 -14.61%
Jun 30, 2024 -13.38%
Mar 31, 2024 -18.00%
Dec 31, 2023 -28.29%
Sep 30, 2023 -24.27%
Jun 30, 2023 -30.79%
Mar 31, 2023 -51.82%
Dec 31, 2022 -48.30%
Sep 30, 2022 -39.11%
Jun 30, 2022 -34.48%
Mar 31, 2022 -30.12%
Dec 31, 2021 -26.67%
Sep 30, 2021 -24.77%
API Access

Viking Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=VKTX&period=max&api_key=YOUR_API_KEY